Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00229164
Other study ID # 9361701148
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received September 27, 2005
Last updated December 26, 2012
Start date October 2005
Est. completion date January 2006

Study information

Verified date November 2012
Source National Taiwan University Hospital
Contact n/a
Is FDA regulated No
Health authority Taiwan: Department of Health
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the effect of high frequency TENS and compare to the placebo effect by sham TENS in a randomized control study.


Description:

Over 50% of American women suffered from dysmenorrhea and 10% of them will take sick leave for 1-2 days. Previous randomized control studies have demonstrated the pain relief effect of using high frequency TENS in dysmenorrheal pain. However, no investigation has been conducted to investigate the effect of high frequency TENS in female population in our country. The purpose of this study is to investigate the effect of high frequency TENS and compare to the placebo effect by sham TENS in a randomized control study.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date January 2006
Est. primary completion date
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- primary Dysmenorrhea

Exclusion Criteria:

- subjects with organic disorders

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Transcutaneous Electric Nerve Stimulation (TENS)


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary all measure the pain threshold,
Primary self-rating questionnaire